EVERY CURE INC

3. Education and awareness-raising on drug repurposing(continued on schedule o)every cure, inc. Educates physicians, researchers, patients, policymakers, and the general public about the potential for drug repurposing to accelerate cures. Education and outreach are central to creating a shift in medicine, where existing therapies are fully leveraged for diseases beyond their original approvals.specific accomplishments include: educational programs and workshops: organized scientific convenings such as the chan zuckerberg initiative (czi)-supported workshop on rare disease drug repurposing, which brought together leading experts across academia, industry, and government to share knowledge and define collaborative pathways. Professional outreach: disseminated findings through presentations at international scientific meetings, invited talks at research institutions, and publication of educational content in professional outlets to increase awareness among physicians and scientists. Patient and public engagement: leveraged media exposure, social media campaigns, and direct patient community engagement to increase understanding of drug repurposing opportunities, empowering patients to discuss potential options with their physicians. Roadmap development: advanced the roadmap initiative, a framework for how to systematically identify and validate repurposing opportunities for rare diseases, providing a replicable resource for the field. Digital awareness: reached millions through media features and social media, highlighting the story of drug repurposing and every cure's mission, increasing visibility and engagement with our work.through these activities, every cure has created a foundation of knowledge and awareness that will help to accelerate the pace of drug repurposing across the healthcare ecosystem.